What is the best medication for treating unwanted facial hair growth (hirsutism) in adult women without contraindications to estrogen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Best Medication for Unwanted Facial Hair Growth

For adult women without contraindications to estrogen, oral contraceptive pills (OCPs) are the recommended first-line pharmacological treatment for unwanted facial hair growth, with the addition of an antiandrogen (spironolactone 100-200 mg/day or finasteride 2.5-5 mg/day) after 6 months if response is inadequate 1.

Treatment Algorithm

First-Line Therapy: Oral Contraceptive Pills

OCPs work through multiple mechanisms to reduce hirsutism 1:

  • Suppress LH secretion, thereby reducing ovarian androgen production
  • Increase hepatic production of sex hormone-binding globulin (SHBG), which binds androgens and reduces free testosterone
  • Provide slight reduction in adrenal androgen secretion
  • Offer additional benefits of menstrual regulation and contraception

Any OCP containing 20-35 µg ethinyl estradiol is acceptable, though formulations with less androgenic progestins (norgestimate, desogestrel) or antiandrogenic progestins (drospirenone, cyproterone acetate) have theoretical advantages 1. However, no single OCP formulation has proven superior to others for hirsutism treatment.

Second-Line: Adding an Antiandrogen

If hirsutism remains bothersome after 6 months of OCP monotherapy, add an antiandrogen 1:

Spironolactone 100-200 mg/day (divided twice daily) is the most commonly used antiandrogen:

  • Similar efficacy to other antiandrogens
  • Well-tolerated with minimal side effects
  • More effective than finasteride with prolonged treatment 1

Finasteride 2.5-5 mg/day is an alternative:

  • Reduces hirsutism scores by 30-60% 1
  • Similar efficacy to spironolactone in some trials
  • No major adverse effects reported

Cyproterone acetate (CPA) (not available in the United States):

  • 50-100 mg/day on cycle days 5-15 with ethinyl estradiol, or
  • 2 mg daily as part of an OCP formulation
  • Similar efficacy to other antiandrogens 1

Critical Caveat: Contraception with Antiandrogens

Never use antiandrogen monotherapy without adequate contraception due to teratogenic potential 1. This is a strong recommendation based on the risk of feminization of male fetuses.

Medications to Avoid

Flutamide is NOT recommended for routine management 1:

  • Despite similar efficacy to other antiandrogens (250-500 mg/day)
  • Risk of hepatotoxicity is significant, including liver failure and death
  • Only consider in refractory cases at lowest effective doses with close monitoring

Insulin-lowering drugs (metformin) are NOT recommended 1:

  • Despite one study showing potential benefit 2, guidelines recommend against their use for hirsutism treatment alone
  • May be appropriate for women with concurrent metabolic concerns, but not for hirsutism as primary indication

GnRH agonists are NOT recommended except in severe hyperandrogenemia (ovarian hyperthecosis) unresponsive to OCPs and antiandrogens 1

Glucocorticoids are NOT recommended except for women with nonclassic congenital adrenal hyperplasia who fail OCPs/antiandrogens 1

Timeline Expectations

Allow at least 6 months before changing dose, switching medications, or adding additional therapy 1. Hair growth cycles are slow, and pharmacological effects take time to manifest clinically.

Adjunctive Topical Therapy

Eflornithine hydrochloride cream 13.9% (Vaniqa) can be added to systemic therapy 1:

  • Slows facial hair growth rate (does not remove existing hair)
  • Results visible in 6-8 weeks
  • Can be combined with laser/photoepilation for enhanced effect
  • Minimal systemic absorption with excellent safety profile
  • Side effects limited to mild itching and dry skin

Hair Removal Methods

For women desiring more rapid cosmetic improvement, laser/photoepilation is superior to electrolysis 1:

  • 74% hair reduction vs. 35% with electrolysis at 6 months
  • 60 times faster than electrolysis
  • Less painful
  • Can be used concurrently with pharmacological therapy

Common Pitfalls to Avoid

  1. Starting antiandrogen monotherapy without contraception - Always ensure adequate contraception due to teratogenic risk
  2. Changing therapy too quickly - Hair growth cycles require 6+ months to show response
  3. Using flutamide as first-line - Reserve only for refractory cases due to hepatotoxicity risk
  4. Expecting complete hair removal from medications alone - Pharmacological therapy reduces growth but rarely eliminates all unwanted hair; combination with mechanical removal methods often necessary
  5. Prescribing metformin for hirsutism alone - Not supported by guidelines unless metabolic indications exist

References

2
Research

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.

The Journal of clinical endocrinology and metabolism, 2003

Related Questions

What is the approach and treatment for a post-menopausal woman presenting with hirsutism, characterized by beard hair growth?
In a 33-year-old woman with hirsutism, what is the appropriate diagnostic workup and treatment options?
In a 70-year-old female with hirsutism, which laboratory tests should be ordered?
What is the most appropriate next step in evaluating a 28‑year‑old woman with irregular menstrual cycles since delivering a child 2.5 years ago, 25 kg weight gain, mild facial hirsutism, normal free and total testosterone, low dehydroepiandrosterone sulfate (DHEAS), and normal thyroid‑stimulating hormone (TSH)?
Can Primary Hyperparathyroidism (PTH) cause hirsutism in women?
Is persistent soreness at the tetanus injection site one month after vaccination normal, or does it suggest infection that requires medical evaluation?
What diagnostic tests should be ordered to evaluate a possible intracranial hemorrhage?
What is the recommended cross‑switch protocol from risperidone to aripiprazole (Abilify) for an autistic patient who is stable on risperidone?
What are the typical symptoms of an acute urinary tract infection?
Can I take cetirizine (Zyrtec) while taking sertraline (Zoloft) 50 mg daily?
What are the current guidelines for surveillance of abdominal aortic ectasia and abdominal aortic aneurysm?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.